Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome
Product Details Brand: Novo Nordisk Size: 3 ml Category: Prescription medication for weight management Usage: Weekly subcutaneous injection Storage Instructions Store in the refrigerator at 28C
2.4% placebo) 86.4% of participants lost at least 5% of body weight 69.1% lost at least 10% 50.5% lost at least 15% STEP 3 (Wadden et al., 2021, JAMA ): Combined with intensive behavioral therapy Average weight loss: 16.0% over 68 weeks Demonstrated that lifestyle support amplifies medication effects STEP 5 (Garvey et al., 2022, Nature Medicine ): Two-year duration study Average weight loss: 15.2% maintained over 104 weeks Demonstrated sustained effectiveness with continued use Retatrutide Clinical Trial Results Phase 2 Trial (Jastreboff et al., 2023, NEJM ): 338 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Multiple dose groups (1 mg, 4 mg, 8 mg, 12 mg weekly) Results at the 12 mg dose: Average weight loss: 24.2% in 48 weeks 100% of participants lost at least 5% of body weight 93% lost at least 10% 83% lost at least 15% 63% lost at least 20% Weight loss trajectory had not plateaued at study end Comprehensive Comparison Table Side Effects Comparison Both medications share similar gastrointestinal side effect profiles because they both activate GLP-1 receptors
Our medical weight loss program includes provider guidance built around your health history, body composition scans to track muscle and visceral fat rather than just weight, nutrition and lifestyle coaching, and ongoing support between visits
They bypass digestion to provide 100% absorption, replenishing natural antioxidant levels that protect against toxins, stress, and free-radical damage
